Document is current
Any future updates will be listed below
-
Authors
Schmidt, Rose A.
Guta, Adrian
Rai, Nanky
Sereda, Andrea
O’Reilly, Emmet
Hales, Jessica
Kolla, Gillian
Strike, Carol
-
Funding
Funding for this research was provided by:
Ontario HIV Treatment Network (EFP-1113)
- License Information
-
More Information
Article History
Received: 25 August 2023
Accepted: 11 October 2024
First Online: 10 December 2024
Declarations
:
: The study was approved by the University of Toronto Research Ethics Board (Protocol: 40140).
: All participants provided verbal consent.
: Not applicable.
: Schmidt, Guta, and Strike have no conflicts to declare. Rai is a prescriber in the Safer Opioid Supply program based out of the Parkdale Queen West Community Health Centre. Sereda is a prescriber in the Safer Opioid Supply program based out of the London InterCommunity Health Centre. O’Reilly is a prescriber in the Safer Opioid Supply program based out of the South Riverdale Community Health Centre and his position is partially funded through the Centre on Drug Policy Evaluation. Hales is a prescriber in the Safer Opioid Supply program based out of the Regent Park Community Health Centre. Kolla is supported by a Banting postdoctoral fellowship from CIHR and a postdoctoral fellowship from the Canadian Network on Hepatitis C (CanHepC). Separate from this study, Kolla received funding from London InterCommunity Health Centre’s Substance Use and Addictions Program grant to conduct an independent preliminary evaluation of their Safer Opioid Supply program.
